• Home
    Foundation’s Origins Joanna’s Story Board of Directors Honorary Board Advisory Board Accomplishments
  • Prevention
    JMNMF Awareness Programs Overview Sun Safe Practices The Sun’s UV Rays Tanning Beds Risk Factors of Melanoma Sunscreen Guidelines More Information for Kids
  • Detection
    Overview The A, B, C’s Other Early Warning Signs Self Exams Screenings
  • Care
    What to Expect when Diagnosed Importance of Staging Treatment Follow-up Care Where to Go for Help
  • Cure
    Importance of Research Research Activities Clinical Trials
  • "WIN-THE-FIGHT"
    About Team “WIN-THE-FIGHT” Frederick Kids Triathlon South Carroll Sprint Triathlon Garrett County Gran Fondo SavageMan Festival MD Youth Triathlon Series
  • How to Help
    Volunteer Become a Sponsor Donate to the Foundation Honor a Loved One

GOT SKIN? LEARN THESE ALARMING FACTS:

  • Besides Skin Cancer - Both UVA and UVB rays damage the eyes and immune system; wrinkle the skin and cause premature aging.

  • In 2012, 76,250 NEW cases of melanoma are projected to be diagnosed in the U.S.; and 9,180 individuals are expected to die, up 8;5% and 4.5% respectively over 2011

Help Fund the Foundation


Foundation Accomplishments

Upcoming Events

March 1, 2012 – Research Scholar Awards Announced

April 18, 2012 JMNMF Board of Directors Meeting

May 26, 2012 Frederick Kids Triathlon

June 17, 2012 South Carroll Sprint Triathlon

June 23, 2012 Garret County Gran Fondo

September 15-16, 2012 SavageMan Festival

See Full Calendar
Interested in Volunteering?

Subscribe for quarterly Melanoma Resource e-newsletter and periodic updates (emails not shared outside of JMNMF).

Sign up for our Email Newsletter

For Email Marketing you can trust

Melanoma PSAs
See the Latest Information

Contact Us:

255 Clifton Boulevard, Suite 203
Westminster, MD 21157
Telephone: (410)857-4890
Email: contact@melanomaresource.org

Care / Follow-up Care

Follow-up of patients with melanoma, after completion of the initial treatment intervention, is essential. 

Depending upon the stage of the disease, it is suggested that the patient be evaluated 1-4 times a year for the first two years and then 1-2 times per year thereafter. 

Follow-up is aimed at the early detection of metastatic disease and new primary sites of melanoma.

  • Home
  • About Us
  • Related Links